Ildong Pharmaceutical Co., Ltd. (KRX:249420)

South Korea flag South Korea · Delayed Price · Currency is KRW
21,000
-400 (-1.87%)
Last updated: May 19, 2026, 12:15 PM KST
Market Cap674.27B +113.1%
Revenue (ttm)566.93B -7.8%
Net Income27.66B
EPS936.77
Shares Out31.51M
PE Ratio22.84
Forward PE16.45
Dividend200.00 (0.90%)
Ex-Dividend DateMar 30, 2026
Volume108,516
Average Volume252,141
Open21,050
Previous Close21,400
Day's Range20,750 - 21,950
52-Week Range11,350 - 45,050
Beta0.98
RSI26.38
Earnings DateMay 13, 2026

About Ildong Pharmaceutical

Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-histamine drugs, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients; and drugs for blood circulation, cardiovascular and central nervous system, dental, endocrine and metabolic system, gastrointestinal system, respiratory system, topical preparation, and urogenital system... [Read more]

Sector Healthcare
Founded 1941
Country South Korea
Stock Exchange Korea Stock Exchange
Ticker Symbol 249420
Full Company Profile

Financial Performance

Financial Statements